The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors
Official Title: An Extension Study to Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors.
Study ID: NCT01193140
Brief Summary: To evaluate the safety and tolerability of the veliparib/TMZ combination in subjects with solid tumors.
Detailed Description: An extension study to evaluate the safety of veliparib in combination with temozolomide in subjects with solid tumors
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Site Reference ID/Investigator# 43022, Encinitas, California, United States
Site Reference ID/Investigator# 42662, Santa Monica, California, United States
Name: Bhardwaj Dessai, MD
Affiliation: Abbott
Role: STUDY_DIRECTOR